• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型精神活性物质:欧盟信息交流和创新法律应对的演变。

New Psychoactive Substances: Evolution in the Exchange of Information and Innovative Legal Responses in the European Union.

机构信息

National Center on Addiction and Doping, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy.

International School of Advanced Studies (ISAS), University of Camerino, Piazza Cavour 19/f, 62032 Camerino, Italy.

出版信息

Int J Environ Res Public Health. 2020 Nov 23;17(22):8704. doi: 10.3390/ijerph17228704.

DOI:10.3390/ijerph17228704
PMID:33238595
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7709051/
Abstract

At the end of 2019, the European Monitoring Centre for Drugs and Drug Addiction was monitoring around 790 new psychoactive substances, more than twice the total number of controlled substances under the United Nations Conventions. These substances, which are not subject to international drug controls, include a wide range of molecules, including the assortment of drugs such as synthetic cannabinoids, stimulants, opiates, and benzodiazepines. Most of them are sold as "legal" substitutes for illicit drugs, while others are intended for small groups willing to experiment with them in order to know their possible new effects. At the national level, various measures have been taken to control new substances and many European countries have responded with specific legislation in favor of consumer safety and by extending or adapting existing drug laws to incorporate the new psychoactive substances. Moreover, since 1997, an early warning system has been created in Europe for identifying and responding quickly to the risks of new psychoactive substances. In order to establish a quicker and more effective system to address the criminal activities associated with new dangerous psychoactive substances, the European legal framework has considerably changed over the years.

摘要

2019 年底,欧洲毒品和毒瘾监测中心正在监测约 790 种新精神活性物质,是受《联合国公约》管制的物质总数的两倍多。这些不受国际毒品管制的物质包括范围广泛的分子,包括合成大麻素、兴奋剂、阿片类药物和苯二氮䓬类药物等各种药物。其中大部分被作为非法药物的“合法”替代品出售,而其他物质则是供愿意尝试了解其可能的新作用的小群体使用。在国家层面,已经采取了各种措施来控制新物质,许多欧洲国家已经采取了具体的立法措施,以保障消费者安全,并通过扩大或调整现有毒品法,将新精神活性物质纳入其中。此外,自 1997 年以来,欧洲建立了一个早期预警系统,以识别和快速应对新精神活性物质的风险。为了建立一个更快、更有效的系统来应对与新的危险精神活性物质相关的犯罪活动,欧洲法律框架近年来发生了重大变化。

相似文献

1
New Psychoactive Substances: Evolution in the Exchange of Information and Innovative Legal Responses in the European Union.新型精神活性物质:欧盟信息交流和创新法律应对的演变。
Int J Environ Res Public Health. 2020 Nov 23;17(22):8704. doi: 10.3390/ijerph17228704.
2
Responding to New Psychoactive Substances in the European Union: Early Warning, Risk Assessment, and Control Measures.应对欧盟新型精神活性物质:早期预警、风险评估及控制措施
Handb Exp Pharmacol. 2018;252:3-49. doi: 10.1007/164_2018_160.
3
The drug situation in Europe: an overview of data available on illicit drugs and new psychoactive substances from European monitoring in 2015.欧洲毒品形势:对 2015 年欧洲毒品监测中非法药物和新精神活性物质相关数据的概述。
Addiction. 2016 Jan;111(1):34-48. doi: 10.1111/add.13056. Epub 2015 Sep 30.
4
From JWH-018 to OXIZIDS: Structural evolution of synthetic cannabinoids in the European Union from 2008 to present day.从JWH-018到氧氮杂环类化合物:2008年至今欧盟合成大麻素的结构演变。
Drug Test Anal. 2023 Apr;15(4):378-387. doi: 10.1002/dta.3422. Epub 2022 Dec 20.
5
The complex and constantly evolving public health threat of new psychoactive substances in Italy: addressing the main functions of a national observatory of drugs.意大利新精神活性物质这一复杂且不断演变的公共卫生威胁:应对国家药物观察站的主要职能。
Ann Ist Super Sanita. 2021 Apr-Jun;57(2):144-150. doi: 10.4415/ANN_21_02_06.
6
Monitoring psychoactive substance use at six European festivals through wastewater and pooled urine analysis.通过污水和混合尿液分析监测六个欧洲节日中的精神活性物质使用情况。
Sci Total Environ. 2020 Jul 10;725:138376. doi: 10.1016/j.scitotenv.2020.138376. Epub 2020 Apr 3.
7
European dimension of cannabinoid-like products use.大麻素类产品使用的欧洲层面情况
J Med Life. 2012 Feb 22;5(1):79-81. Epub 2012 Mar 5.
8
A systematic review of the effects of novel psychoactive substances 'legal highs' on people with severe mental illness.新型精神活性物质“合法兴奋剂”对重症精神疾病患者影响的系统评价
J Psychiatr Ment Health Nurs. 2016 Jun;23(5):267-81. doi: 10.1111/jpm.12297. Epub 2016 Apr 1.
9
Collaboration of the Joint Research Centre and European Customs Laboratories for the Identification of New Psychoactive Substances.联合研究中心与欧洲海关实验室在新型精神活性物质鉴定方面的合作。
Curr Pharm Biotechnol. 2018;19(2):91-98. doi: 10.2174/1389201019666180523122717.
10
New psychoactive substances: concerted efforts and common legislative answers for stemming a growing health hazard.新精神活性物质:协调努力和共同立法对策遏制日益严重的健康危害。
Eur Rev Med Pharmacol Sci. 2019 Nov;23(22):9681-9690. doi: 10.26355/eurrev_201911_19529.

引用本文的文献

1
Socio-demographic and toxicological findings from autoptic cases in a Northern Italy community (2017-2022).意大利北部一个社区(2017 - 2022年)尸检病例的社会人口统计学和毒理学研究结果
Int J Legal Med. 2025 May;139(3):1093-1104. doi: 10.1007/s00414-025-03433-1. Epub 2025 Feb 3.
2
75 years of forensic profiling: A critical review.75年的法医画像:批判性综述。
Heliyon. 2024 Oct 18;10(20):e39490. doi: 10.1016/j.heliyon.2024.e39490. eCollection 2024 Oct 30.
3
Synthetic Cathinones: Epidemiology, Toxicity, Potential for Abuse, and Current Public Health Perspective.

本文引用的文献

1
Pharmacological Human Enhancement: An Overview of the Looming Bioethical and Regulatory Challenges.人类药理学增强:迫在眉睫的生物伦理与监管挑战概述
Front Psychiatry. 2020 Feb 17;11:53. doi: 10.3389/fpsyt.2020.00053. eCollection 2020.
2
New psychoactive substances: concerted efforts and common legislative answers for stemming a growing health hazard.新精神活性物质:协调努力和共同立法对策遏制日益严重的健康危害。
Eur Rev Med Pharmacol Sci. 2019 Nov;23(22):9681-9690. doi: 10.26355/eurrev_201911_19529.
3
New psychoactive substances: challenges for drug surveillance, control, and public health responses.
合成卡西酮:流行病学、毒性、滥用潜力及当前公共卫生视角
Brain Sci. 2024 Mar 29;14(4):334. doi: 10.3390/brainsci14040334.
4
Deep Learning-Enabled MS/MS Spectrum Prediction Facilitates Automated Identification Of Novel Psychoactive Substances.深度学习助力 MS/MS 谱预测,助力新型精神活性物质的自动鉴定。
Anal Chem. 2023 Dec 19;95(50):18326-18334. doi: 10.1021/acs.analchem.3c02413. Epub 2023 Dec 4.
5
New Psychoactive Substances: A Potential Threat to Developing Countries.新型精神活性物质:对发展中国家的潜在威胁。
Addict Health. 2023 Apr;15(2):136-143. doi: 10.34172/ahj.2023.1411. Epub 2023 Apr 29.
6
Synthetic cannabinoids awareness among patients with opioid use disorder in Serbia - A survey based cross-sectional pilot study.塞尔维亚阿片类物质使用障碍患者对合成大麻素的认知——一项基于调查的横断面试点研究。
Front Psychiatry. 2023 Mar 7;14:987726. doi: 10.3389/fpsyt.2023.987726. eCollection 2023.
7
A review of synthetic cathinones emerging in recent years (2019-2022).近年来(2019-2022 年)新兴合成卡西酮综述。
Forensic Toxicol. 2023;41(1):25-46. doi: 10.1007/s11419-022-00639-5. Epub 2022 Sep 15.
8
An Update on the Implications of New Psychoactive Substances in Public Health.新精神活性物质对公共健康影响的最新研究进展。
Int J Environ Res Public Health. 2022 Apr 17;19(8):4869. doi: 10.3390/ijerph19084869.
9
Comparison of LC-MS and LC-DAD Methods of Detecting Abused Piperazine Designer Drugs.液相色谱-质谱联用(LC-MS)法与液相色谱-二极管阵列检测法(LC-DAD)检测滥用的哌嗪类新型毒品的比较。
J Clin Med. 2022 Mar 22;11(7):1758. doi: 10.3390/jcm11071758.
10
Rapid Targeted Method of Detecting Abused Piperazine Designer Drugs.检测滥用哌嗪类新型毒品的快速靶向方法。
J Clin Med. 2021 Dec 12;10(24):5813. doi: 10.3390/jcm10245813.
新型精神活性物质:药物监测、管制和公共卫生应对措施面临的挑战。
Lancet. 2019 Nov 2;394(10209):1668-1684. doi: 10.1016/S0140-6736(19)32231-7. Epub 2019 Oct 23.
4
Comparison of legislative management for new psychoactive substances control among Taiwan, South Korea, and Japan.比较台湾、韩国和日本管制新精神活性物质的立法管理
Kaohsiung J Med Sci. 2020 Feb;36(2):135-142. doi: 10.1002/kjm2.12140. Epub 2019 Oct 23.
5
New Psychoactive Substances: A Matter of Time.新精神活性物质:时间问题。
Curr Neuropharmacol. 2019;17(9):818-822. doi: 10.2174/1570159X1709190729101751.
6
Ultra-High-Performance Liquid Chromatography-Tandem Mass Spectrometry Assay for Quantifying Fentanyl and 22 Analogs and Metabolites in Whole Blood, Urine, and Hair.用于定量全血、尿液和毛发中芬太尼及其22种类似物和代谢物的超高效液相色谱-串联质谱分析法
Front Chem. 2019 Apr 2;7:184. doi: 10.3389/fchem.2019.00184. eCollection 2019.
7
Use of cognitive enhancers: methylphenidate and analogs.认知增强剂的使用:哌醋甲酯及其类似物。
Eur Rev Med Pharmacol Sci. 2019 Jan;23(1):3-15. doi: 10.26355/eurrev_201901_16741.
8
Responding to New Psychoactive Substances in the European Union: Early Warning, Risk Assessment, and Control Measures.应对欧盟新型精神活性物质:早期预警、风险评估及控制措施
Handb Exp Pharmacol. 2018;252:3-49. doi: 10.1007/164_2018_160.
9
Pharmacotoxicology of Non-fentanyl Derived New Synthetic Opioids.非芬太尼衍生新型合成阿片类药物的药物毒理学
Front Pharmacol. 2018 Jun 20;9:654. doi: 10.3389/fphar.2018.00654. eCollection 2018.
10
European Drug Users at Risk from Illicit Fentanyls Mix.欧洲吸毒者面临非法芬太尼混合物的风险。
Front Pharmacol. 2017 Oct 31;8:785. doi: 10.3389/fphar.2017.00785. eCollection 2017.